Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the 32 nd Annual J.P. Morgan Healthcare Conference in San Francisco on January 13, 2014. Joe Almeida, Chairman, President and Chief Executive Officer, will discuss the company in a presentation scheduled to begin at 8:30 a.m. PT (11:30 a.m. ET). A live audio webcast of the presentation can be accessed at Covidien’s Investor Relations website: http://investor.covidien.com. An archived edition of the presentation will be available following the live webcast. ABOUT COVIDIEN Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien develops, manufactures and sells a diverse range of industry-leading medical device and supply products. With 2013 revenue of $10.2 billion, Covidien has more than 38,000 employees worldwide in more than 70 countries, and its products are sold in over 150 countries. Please visit www.covidien.com to learn more about our business.
Ikaria, which focuses on therapies for critically ill infants, is privately owned by a group led by Madison Dearborn Partners. Buyer Mallinckrodt specializes in diagnostic radiology and pain management.